{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/leg-ulcer-venous/prescribing-information/flucloxacillin/","result":{"pageContext":{"chapter":{"id":"314a80d5-e16b-5625-8d64-4141535ff392","slug":"flucloxacillin","fullItemName":"Flucloxacillin","depth":2,"htmlHeader":"<!-- begin field d09898b9-6bb4-4f27-8512-930826612e0a --><h2>Flucloxacillin</h2><!-- end field d09898b9-6bb4-4f27-8512-930826612e0a -->","summary":"","htmlStringContent":"<!-- begin item de0eb2be-9e5a-475b-abeb-dc6ccbec630d --><!-- end item de0eb2be-9e5a-475b-abeb-dc6ccbec630d -->","topic":{"id":"627b2b3c-014b-5543-8f89-0f3ffa6344ad","topicId":"4c5db985-9544-48b2-8c54-8915ec210739","topicName":"Leg ulcer - venous","slug":"leg-ulcer-venous","lastRevised":"Last revised in January 2021","chapters":[{"id":"01818c5e-efb9-59c4-b339-08b834294232","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"313e84c5-8bc7-5150-826a-467ea7252acd","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"2597db24-8ec5-54d4-86ad-8082be50f4f6","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"38f24092-0019-582d-86bf-d1f61bccde1d","slug":"changes","fullItemName":"Changes"},{"id":"cdc15e74-0503-53a5-a4be-c53ec4e20898","slug":"update","fullItemName":"Update"}]},{"id":"73d0cf59-f9c0-5785-8c74-e756826d5d1e","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"64b11689-d52a-560f-8d9b-c592d654615e","slug":"goals","fullItemName":"Goals"},{"id":"ac3d1637-467f-5edb-8fd8-73f66160080f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"4bffe5b2-0ce0-5ae8-8c0b-914bb6ed5a1d","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"82441da5-60f5-53b4-b510-187f7bacb4a8","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"3e5817d5-30e7-54b7-b9ba-224b4a295bba","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b30bb006-efbc-5a69-90f3-30abf232a97d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"84dc0da0-8533-5c5d-99f6-7c04a116701a","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"45d8d35d-9757-544c-b04e-9747898a1f0e","slug":"definition","fullItemName":"Definition"},{"id":"21acb832-e5e8-5bd1-9b8d-9410ec5011bf","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"cf27bd7b-b787-5def-bb40-ee0f134a8aca","slug":"prevalence","fullItemName":"Prevalence"},{"id":"a55a1739-f3d2-534c-b533-f6406d9c81ea","slug":"complications","fullItemName":"Complications"},{"id":"683b612a-3f1d-5580-951b-e14672f52b4a","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"dbc94220-a914-56d0-883d-d158da511e1c","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"57b3b7a5-9042-53fa-a236-56d0d02b647e","slug":"assessment","fullItemName":"Assessment"},{"id":"35ee8784-602e-5a29-9ccf-65b3c3f940d2","slug":"interpretation-of-abpi","fullItemName":"Interpretation of ABPI"},{"id":"0c766f2c-0c8f-521b-85fd-e947ba6b2d09","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"5e199f8a-7621-5318-9da1-264db8f544b8","fullItemName":"Management","slug":"management","subChapters":[{"id":"c8bda10b-ebb6-533b-9c91-96efa5ddf0c3","slug":"venous-leg-ulcers","fullItemName":"Scenario: Venous leg ulcers"}]},{"id":"e084faba-a409-53ac-aa53-08b80a3991f1","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"66a7f656-c6f5-57a2-a08a-1533a6fd4e92","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"a6cda703-9039-5115-b3d3-478cdb4d1e55","slug":"co-amoxiclav","fullItemName":"Co-amoxiclav"},{"id":"1cf75cbb-8bc4-58cc-9a1b-11516db5ad2c","slug":"co-trimoxazole","fullItemName":"Co-trimoxazole"},{"id":"3f0efc32-779b-56f6-85ca-e46a59745bed","slug":"doxycycline","fullItemName":"Doxycycline"},{"id":"fe306aab-d8d7-5181-a461-128f2aa3c65a","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"314a80d5-e16b-5625-8d64-4141535ff392","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"b7e7b8ec-799c-5ea5-9ac0-11935f899b8a","slug":"oral-analgesia","fullItemName":"Oral analgesia"},{"id":"43ed3b03-6322-5690-8f85-b6e10a0b3d3e","slug":"pentoxifylline","fullItemName":"Pentoxifylline"}]},{"id":"19f3ffbe-f365-5196-8586-0dceeaf69908","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"89207239-b8a4-50ce-8b2d-3065a830c0af","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"45831e7c-0e6f-50f3-a513-fe4fcacff65e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3d90cdb0-b2fd-5bfd-bd2d-342e36901f9d","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"8b66d1a4-6ee5-5556-b671-204219a81787","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"5b8ee442-8da6-524f-bf34-e6a9cc2a771e","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6fa96be3-beae-51f6-9f1c-4d278b058d09","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"e75dc366-237b-55d2-a654-2e3bf503b955","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"e084faba-a409-53ac-aa53-08b80a3991f1","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"273ed162-2ee2-5bc2-861a-fc64d0804183","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field b91847bb-de36-4a1d-a113-9bc0aaca5464 --><h3>What are the contraindications and cautions for flucloxacillin?</h3><!-- end field b91847bb-de36-4a1d-a113-9bc0aaca5464 -->","summary":"","htmlStringContent":"<!-- begin item 90b3dd9c-3fe9-4297-aa7e-706af1314bc3 --><!-- begin field d092fb25-7917-4417-b59d-71e3f691655b --><ul><li><strong>Do not prescribe </strong><strong>flucloxacillin</strong> <strong>to people with:</strong><ul><li>A <em>true </em>penicillin hypersensitivity.<ul><li><strong>Note that</strong> gastrointestinal adverse effects alone (such as nausea, vomiting, or diarrhoea) do <em>not </em>constitute an allergy to penicillin. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a> for more information.</li></ul></li><li>A hypersensitivity to cephalosporins — there is some evidence of partial cross-allergenicity. </li><li>A history of penicillin-associated jaundice or hepatic dysfunction.</li></ul></li><li><strong>Prescribe flucloxacillin with caution </strong><strong>in people with:</strong><ul><li>Hepatic impairment (especially if they are 50 years of age or older, or have a serious underlying disease).</li><li>Severe renal impairment — reduce the <a class=\"topic-reference internal-reference\" href=\"/topics/leg-ulcer-venous/management/venous-leg-ulcers/#managing-infection\">dose</a> of flucloxacillin, or the dosing interval, if the estimated glomerular filtration rate (eGFR) is less than 10 mL/minute/1.73 m<sup>2</sup>, due to the risk of neurotoxicity.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">ABPI, 2018g</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">Joint Formulary Committee, 2019</a>]</p><!-- end field d092fb25-7917-4417-b59d-71e3f691655b --><!-- end item 90b3dd9c-3fe9-4297-aa7e-706af1314bc3 -->","subChapters":[]},{"id":"21034ec2-fe29-56f8-8f4e-7c97a9641f1a","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 9ed039da-c2ce-4100-83cb-22d7f065aee4 --><h3>What are the possible adverse effects of flucloxacillin?</h3><!-- end field 9ed039da-c2ce-4100-83cb-22d7f065aee4 -->","summary":"","htmlStringContent":"<!-- begin item b90693a5-3316-414e-b898-097eb0c0d1da --><!-- begin field 0a538d17-98e4-4fe5-8c3a-c3bac02e046e --><ul><li><strong>The most common adverse effects of flucloxacillin </strong>are nausea, vomiting, skin rash, and diarrhoea.<ul><li>Consider pseudomembranous colitis (an acute, exudative colitis caused by <em>Clostridium difficile</em>) if a person develops severe diarrhoea during or after treatment with flucloxacillin. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/diarrhoea-antibiotic-associated/\">Diarrhoea - antibiotic associated</a> for more information.</li></ul></li><li><strong>Anaphylaxis (delayed or immediate)</strong> is a serious but rare adverse effect of flucloxacillin. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a>.</li><li><strong>Hepatitis and cholestatic jaundice</strong> may occur very rarely after treatment with flucloxacillin. These reactions are related neither to the dose nor to the route of administration of flucloxacillin, and the onset may be delayed for several weeks (up to 2 months) after treatment has stopped. Risk factors include treatment for more than 2 weeks and increasing age [<a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">CSM, 1992</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">CSM, 2004</a>].</li><li><strong>Other adverse effects of flucloxacillin include:</strong><ul><li>Rare or very rare — arthralgia, eosinophilia, fever, and myalgia.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">ABPI, 2018g</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">Joint Formulary Committee, 2019</a>]</p><!-- end field 0a538d17-98e4-4fe5-8c3a-c3bac02e046e --><!-- end item b90693a5-3316-414e-b898-097eb0c0d1da -->","subChapters":[]},{"id":"31dfd9a8-b459-5c0f-a200-a316df68ac27","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field 5907b355-5d29-4098-b1ed-409f7e67bc60 --><h3>What are the possible drug interactions with flucloxacillin?</h3><!-- end field 5907b355-5d29-4098-b1ed-409f7e67bc60 -->","summary":"","htmlStringContent":"<!-- begin item ed9040d0-5ebc-48d5-bfd1-6b157bbfe067 --><!-- begin field 6b8f56d8-f52c-4198-aa68-b306817a39bc --><ul><li><strong>Possible drug interactions with flucloxacillin include:</strong><ul><li><strong>Methotrexate</strong> — flucloxacillin is predicted to increase the risk of toxicity when given with methotrexate, and both flucloxacillin and methotrexate can increase the risk of hepatotoxicity.<ul><li>If concurrent treatment is indicated, monitor methotrexate levels more closely. One recommendation is to carry out twice weekly platelet and white cell counts for 2 weeks initially, with the measurement of methotrexate levels if toxicity is suspected.</li></ul></li><li><strong>Food</strong> — the absorption of flucloxacillin may be reduced by food.  <ul><li>Advise that flucloxacillin should be taken one hour before food or on an empty stomach.</li></ul></li><li><strong>Warfarin</strong> — flucloxacillin potentially alters the anticoagulant effect of warfarin.<ul><li>Monitor the prothrombin time or international normalized ratio (INR) more closely with the addition or withdrawal of flucloxacillin. Adjustment of the warfarin dose may be necessary.</li></ul></li></ul></li><li><strong>Oral hormonal contraception</strong> — additional contraceptive precautions are not required during or after courses of penicillins [<a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">FSRH, 2017</a>].<ul><li>However, advise women on the importance of correct contraceptive practice if they experience vomiting or diarrhoea. For further information, see the section on vomiting or diarrhoea in the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-combined-hormonal-methods/\">Contraception - combined hormonal methods</a> and <a class=\"topic-reference external-reference\" href=\"/topics/contraception-progestogen-only-methods/\">Contraception - progestogen-only methods</a>.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">ABPI, 2018g</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">Joint Formulary Committee, 2019</a>]</p><!-- end field 6b8f56d8-f52c-4198-aa68-b306817a39bc --><!-- end item ed9040d0-5ebc-48d5-bfd1-6b157bbfe067 -->","subChapters":[]},{"id":"488fbac8-39d4-5d13-b418-591fc843b843","slug":"use-in-pregnancy-breastfeeding","fullItemName":"Use in pregnancy and breastfeeding","depth":3,"htmlHeader":"<!-- begin field d11d55e5-a8d4-4f8e-9318-aaa300e3bd3c --><h3>Can flucloxacillin be used during pregnancy and breastfeeding?</h3><!-- end field d11d55e5-a8d4-4f8e-9318-aaa300e3bd3c -->","summary":"","htmlStringContent":"<!-- begin item 6b6631f5-a61a-4d0d-b45c-aaa300e3bd0a --><!-- begin field a306b5a8-15c2-4626-a6db-aaa300e3bd3c --><ul><li><strong>Pregnancy</strong><ul><li>Flucloxacillin is not known to be harmful in pregnancy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">Joint Formulary Committee, 2019</a>].</li><li>The vast majority of the large amount of available data shows no increased risk of congenital malformation, spontaneous abortion, intrauterine death, low birth weight, preterm delivery, or neonatal complications following maternal exposure to therapeutic doses of penicillins [<a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">UKTIS, 2017b</a>].</li></ul></li><li><strong>Breastfeeding</strong><ul><li>Trace amounts of flucloxacillin are found in breastmilk, but it is appropriate to use in women who are breastfeeding [<a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">Joint Formulary Committee, 2019</a>].</li><li>Penicillins (and cephalosporins) are the antibiotics of choice in breastfeeding women [<a class=\"bibliography-reference internal-reference\" href=\"/topics/leg-ulcer-venous/references/\">Kearney, 2016</a>].</li></ul></li></ul><!-- end field a306b5a8-15c2-4626-a6db-aaa300e3bd3c --><!-- end item 6b6631f5-a61a-4d0d-b45c-aaa300e3bd0a -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}